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ABSTRACT
Chronic obesity and Chagas disease (caused by the protozoan Trypanosoma 
cruzi) represent serious public health concerns. The interrelation between parasite 
infection, adipose tissue, immune system and metabolism in an obesogenic context, 
has not been entirely explored. A novel diet-induced obesity model (DIO) was 
developed in C57BL/6 wild type mice to examine the effect of chronic infection 
(DIO+I) on metabolic parameters and on obesity-related disorders. Dyslipidemia, 
hyperleptinemia, and cardiac/hepatic steatosis were strongly developed in DIO 
mice. Strikingly, although these metabolic alterations were collectively improved 
by infection, plasmatic apoB100 levels remain significantly increased in DIO+I, 
suggesting the presence of pro-atherogenic small and dense LDL particles. Moreover, 
acute insulin resistance followed by chronic hyperglycemia with hypoinsulinemia 
was found, evidencing an infection-related-diabetes progression. These lipid and 
glucose metabolic changes seemed to be highly dependent on TLR4 expression since 
TLR4-/- mice were protected from obesity and its complications. Notably, chronic 
infection promoted a strong increase in MCP-1 producing macrophages with a M2 
(F4/80+CD11c-CD206+) phenotype associated to oxidative stress in visceral adipose 
tissue of DIO+I mice. Importantly, infection reduced lipid content but intensified 
inflammatory infiltrates in target tissues. Thus, parasite persistence in an obesogenic 
environment and the resulting host immunometabolic dysregulation may contribute 
to diabetes/atherosclerosis progression.
INTRODUCTION
The recognition of obesity as a main source of 
human disease including type 2 diabetes (T2D) and 
cardiovascular disorders, has provoked fierce interest 
in metabolic dysfunction, and identified inflammatory 
insulin resistance (IR) as its central pathophysiological 
mechanism [1]. Involvement of toll-like receptor 4 (TLR4) 
signaling in the pathogenesis of metabolic disorders 
has been well documented [2, 3]. The current literature 
demonstrates that TLR4 deficiency protects from IR [4] 
and reduces adipose tissue (AT) and vascular inflammation 
as well as hepatic steatosis after a high-fat diet (HFD) 
[4, 5]. Prominently, pathogenic responses to obesity 
have been ascribed to AT dysfunction that promotes the 
secretion of a large panel of cytokines and chemokines, 
and leads to the initiation of pro-inflammatory events, 
oxidative stress and tissue dysfunction [6]. This process 
involves the coordinated interaction of various cell 
populations comprising the AT stromal vascular fraction 
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(SVF) including AT macrophages (ATMs), which have 
received a great deal of attention due to their progressive 
accumulation during tissue expansion [5, 7]. Many studies 
have sought to categorize ATMs according to the M1/M2 
macrophage system [8]. Although the general consensus 
in the field is that obesity induces the polarization from 
M2 into M1 phenotype [7], several lines of evidence have 
pointed to a predominant and dynamic M2 polarization of 
ATMs during obesity in mice and humans [7, 9-11]. 
Overall, many studies demonstrating the negative 
impact of excess adiposity on immune function have 
focused on the study of artificial metabolic extreme 
models. Although these approaches yield valuable insight 
into human disease, they are limited to describe the non-
extreme forms of obesity-metabolic dysfunction that 
dominate the clinical field [1]. 
Chagas disease is a vector-borne parasitic disease 
caused by infection with the protozoan Trypanosoma 
cruzi. It is estimated that 10 million people are infected 
worldwide and more than 25 million people are at risk of 
infection [12]. In the past decades, mainly as a result of 
increased population migrations, the diagnosed cases have 
increased also in non-endemic countries [13]. Parasite 
persistence eventually results in severe complications in 
the cardiac and gastrointestinal tissues, but it also affects 
the reticuloendothelial system as the liver, spleen, and 
bone marrow. It is now well established that AT is also an 
important reservoir for the parasite [14, 15]. Recently, we 
demonstrated that T. cruzi infection is a potent risk factor 
for non-alcoholic steatohepatitis [16], which is clearly 
associated to obesity-metabolic consequences. 
Even though there is enough evidence of the influx 
of macrophages into AT during the early stage of infection 
[15], the effect of T. cruzi infection on ATMs polarization 
under a chronic obesogenic nutritional challenge has 
been poorly explored. Mechanistically, CD36 scavenger 
receptor has been involved in the development and 
progression of obesity and its cardiometabolic Separate 
complication to [17]. However, the effect of chronic 
T. cruzi infection on CD36 expression in VAT and 
how parasites could modulate host metabolism and 
inflammation remains to be elucidated.
Accordingly, the purpose of this study was to 
develop a chronic and non-extreme diet-induced obesity 
DIO model associated to T2D and cardiovascular 
disorders progression. We evaluated changes in 
morphometric parameters such as expansion of VAT, 
metabolic homeostasis, and systemic inflammation, 
as well as the role of TLR4 signaling in this metabolic 
context. Particularly on VAT, ATMs polarization and CD36 
receptor expression were further analyzed to understand 
chronic host-parasite interaction in an obesity and Chagas 
disease scenario. 
RESULTS
Morphometric and metabolic parameters in 
a diet-induced obesity model and the effect of 
chronic Trypanosoma cruzi infection
To determinate whether medium fat diet (MFD), 
low fructose and a minimal streptozotocin (STZ) dose 
could develop a non-drastic DIO model, we first assessed 
the variation of morphometric parameters in DIO group 
compared to low fat diet (LFD) group for 24 weeks. We 
observed a time-dependent increase in body weight and 
waist diameter in DIO group (Figure 1A-1B). Additionally, 
we evaluated the increment of VAT and found that it 
was significantly higher in DIO than in LFD group at 
12 and 24 weeks (Figure 1C). Interestingly, the effect of 
T. cruzi infection in this DIO model (DIO+I) showed a 
significant reduction in body weight, waist diameter and 
VAT content compared to DIO group (Figure 1A-1D), and 
no significant differences were seen between DIO+I and 
LFD+I groups. 
Furthermore, DIO group showed hyperglycemia 
from 4 to 24 weeks associated to hyperinsulinemia and 
peripheral IR (increase in HOMA-IR) at 12 and 24 weeks 
(Figure 1E-1G). Conversely, DIO+I displayed a significant 
reduction of glycemia during the acute phase of infection 
(at 4 weeks) in relation to DIO group, whereas similar 
glucose levels were reached at 12 and 24 weeks (Figure 
1E). Interestingly, acute IR was observed in DIO+I group 
at 4 weeks, but lately hyperglycemia concomitantly with 
both, low HOMA-IR index and hypoinsulinemia were 
observed, suggesting a progression to a T. cruzi infection-
related-diabetes.
The interaction between diet and T. cruzi infection 
enhances the development of cardiovascular 
disorders
The risk of developing cardiovascular alterations 
was assessed by determining plasma triglycerides 
(TG) and total cholesterol (TC) levels together with a 
lipoprotein electrophoretic analysis. The highest levels 
of TG and TC were demonstrated in DIO group at 24 
weeks compared to LFD and DIO+I groups. Interestingly, 
although DIO+I improved dyslipidemia compared to 
DIO group (24 weeks), plasmatic apoB100 levels were 
significantly increased in all groups compared to LFD, 
suggesting the presence of pro-atherogenic small and 
dense LDL particles (Figure 2A-2C). 
In addition, heart tissue from DIO group showed 
ectopic lipid accumulation and a slight inflammatory cell 
infiltration at 12 weeks (Figure 2D). Conversely, DIO+I 
group revealed a minor lipid deposition with an increased 
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Figure 1: Changes in morphometric and metabolic parameters associated to a diet-induced obesity model and T. 
cruzi infection. All parameters were registered at 4, 12 and 24 weeks in mice from LFD, DIO, DIO+I and LFD+I groups. Body mass 
abnormalities were analyzed by A. body weight in grams, B. waist diameter in centimeters, and C. visceral adipose tissue expansion 
expressed as the percentage of tissue weight in relation to total body weight. D. Representative image of a mouse from each group at 24 
weeks. Determinations of plasma levels of E. glucose, F. insulin, and G. HOMA-IR were made. Data are shown as mean ± SEM of ten 
mice per group from one experiment representative of two performed. Significance of differences using two-way ANOVA is indicated as 
follows: DIO vs. LFD: *** p < 0.001, ** p < 0.01, * p < 0.05. DIO vs. DIO+I: ффф p < 0.001, фф p < 0.01, ф p < 0.05. 
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inflammatory cell infiltration. Amastigote nests were not 
observed at 12 and 24 weeks, findings which are clearly 
compatible with a chronic Chagas myocardiopathy (Figure 
2D). Likewise, abdominal aorta images in DIO group 
showed disturbances in the epithelium architecture with 
the presence of hypertrophied adventitial adipocytes, 
whereas these type of alterations were not observed in 
DIO+I group (Figure 2E). However, an increased number 
of infiltrating cells on the aorta´s adventitia was found in 
this infected group (Figure 2E).
Figure 2: The interaction between diet and T. cruzi infection enhances the development of cardiovascular disorders. 
Lipid metabolism was analyzed by the measurements of plasma levels of A. triglycerides and B. total cholesterol after 12h fasting in mice 
from either LFD, DIO, DIO+I or LFD+I groups. C. Lipoprotein pattern was assessed by electrophoresis. ApoB100 was quantified at 24 
weeks and analyzed by one-way ANOVA: DIO, DIO+I and LFD+I vs. LFD: * p < 0.05. D. A representative hematoxylin and eosin image 
of heart tissue from each group is shown (400x). The arrows represent inflammatory foci (white) and lipid deposition (black). Scale bar 
= 20μm. E. A representative hematoxylin and eosin image of abdominal aorta from each group is shown (400x). The arrows represent 
inflammatory foci (white) and lipid deposition (black). Data are shown as mean ± SEM of seven mice per group from one experiment 
representative of two performed. Statistical analysis was made by using two-way ANOVA test as follows: DIO vs. LFD: *** p < 0.001, ** p < 
0.01, * p < 0.05, and DIO vs. DIO+I: ф p < 0.05, ффф p < 0.001. 
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With the aim of studying the role of TLR4 signaling 
in our model, several metabolic parameters were measured 
in TLR4-deficient (TLR4-/-) mice. TLR4-/- DIO mice 
showed a significant reduction in body weight compared 
to WT from 4 to 24 weeks, while no significant changes 
were observed between TLR4-/- DIO and TLR4-/- LFD 
groups (Figure 3A). Importantly, VAT percentage was 
significantly decreased in TLR4-/- DIO group in relation 
to WT group at 12 and 24 weeks (Figure 3B). In addition, a 
significant decrease in glycemia was observed in TLR4-/- 
Figure 3: TLR4 signaling mediates obesity development, glucose and lipid abnormalities triggered by diet and T. cruzi 
infection in this obesity model. A. Body weight, B. percentage of visceral adipose tissue, C. glycemia, D. total cholesterol and E. 
triglycerides plasma levels were compared between WT and TLR4-/- groups. n = seven mice per group. Data are shown as mean ± SEM. 
Statistical studies were performed using two-way ANOVA test. DIO vs. TLR4 -/- DIO: *** p < 0.001, ** p < 0.01, * p < 0.05. DIO+I vs. TLR4 
-/- DIO+I: фф p < 0.01.
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DIO when compared to WT mice. A similar behavior 
was seen between TLR4-/- DIO+I and WT mice (Figure 
3C). Moreover, a significant reduction in TC and TG 
plasma levels was found on TLR4-/- DIO in comparison 
to WT group at 24 weeks (Figure 3D-3E). Data from 
TLR4-/- LFD+I mice were not included as they showed 
an increased susceptibility to T. cruzi infection and 
so, a high mortality during the acute phase of infection 
(Supplemental Figure 1).
Strikingly, a significant decrease in apoB100 levels 
was seen in TLR4-/-DIO and DIO+I in relation to their 
respective WT groups (Supplemental Figure 2).
Figure 4: Diet and infection induce an imbalance of classical pro-inflammatory and leptin/adiponectin cytokines. 
Cytokine levels were quantified by ELISA in plasma obtained at 4, 12 and 24 weeks from LFD, DIO, DIO+I and LFD+I groups: A. IL-6, B. 
TNF-α, C. MCP-1, D. leptin and E. adiponectin. Data are shown as mean ± SEM of seven mice per group. A p-value < 0.05 was considered 
significant using two-way ANOVA test: DIO vs. LFD and DIO vs. DIO+I: *** p < 0.001, ** p < 0.01, * p < 0.05.
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Diet and infection induce an imbalance of 
classical pro-inflammatory and leptin/adiponectin 
cytokines
It has been well documented that chronic 
inflammation occurs in AT mainly due to macrophage 
infiltration during obesity, and this process leads to 
relevant changes in both, metabolic and inflammatory 
responses. In our DIO model, there was a significant 
increase in IL-6 plasma levels compared to LFD group 
only at 24 weeks. However, a significant increase in this 
cytokine was observed at 4 and 24 weeks in the DIO+I 
group, when compared to DIO group (Figure 4A). TNF-α 
showed a significant increase only at 4 weeks in DIO+I 
vs. DIO mice, while no significant changes were observed 
among other groups at the studied times (Figure 4B). 
Similarly, the highest systemic levels of MCP-1 were 
detected in DIO+I group at 4 weeks (Figure 4C).
Hyperleptinemia was found from 4 to 24 weeks in 
all experimental groups compared to LFD (Figure 4D) 
and remarkably, the highest levels were observed in DIO 
group at 12 and 24 weeks. Adiponectin was significantly 
decreased at 4 weeks in all groups compared to LFD 
group. However, its levels remained low only in the 
infected groups at 12 and 24 weeks (Figure 4E).
Figure 5: Diet induces an increased CD36 scavenger receptor expression, and T. cruzi infection exacerbates inflammatory 
cell infiltration and oxidative stress in VAT. A. Representative hematoxylin and eosin images of VAT from DIO and DIO+I mice 
(400x). Inserts are from LFD (on the left) and LFD+I (on the right) mice. Arrowheads and black arrows represent CLSs and inflammatory 
foci, respectively. Scale bar = 40μm. B. Immunoblot of CD36 was performed on VAT lysates at 24 weeks. The quantitative analysis is 
shown and expressed as fold change in CD36 protein expression. Error bars represent SEM, * p < 0.05 (n = 4 per group). C. Extent of lipid 
peroxidation at 24 weeks was evaluated and lipid peroxides were expressed as µmol MDA/µg protein. Data are shown as mean ± SEM 
of six mice per group from one experiment representative of three performed. A p-value < 0.05 was considered significant using one-way 
ANOVA test. 
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It is known that IL-6 and TNF-α cytokines are able 
to stimulate the production of acute phase proteins in liver 
during inflammation. The protein patterns revealed an 
increment in α2 macroglobulin fraction in DIO compared 
to LFD group at 4 weeks. Both, α1 and α2 fractions were 
highly increased in the infected groups compared to 
DIO and LFD groups. Concomitantly, an increase in the 
gamma globulin fraction was found in the infected groups 
(Supplemental Figure 3). 
Figure 6: Increased number of M2- phenotype macrophages and its MCP-1 production are induced by diet and 
exacerbated by T. cruzi infection in VAT. A. Representative images for MCP-1 detection (400x) of epididymal (visceral) AT from 
DIO+I mice at 12 weeks. Rabbit anti-mouse MCP-1 and anti-rabbit conjugated with FITC antibodies were used. Scale bar = 20 µm. B. 
Epididymal AT leukocytes from different groups of mice obtained at 12 weeks, and C. the absolute numbers of F4/80+CD11c+CD206- (M1) 
and F4/80+CD11c-CD206+ (M2) cells are shown. D. The absolute number of MCP-1 producing F4/80+ CD11c+ (M1) and F4/80+CD206+ 
(M2) cells of epididymal AT are shown. Assays were performed by flow cytometry and shown as mean ± SEM of six mice from one 
experiment representative of two performed: *** p < 0.001. 
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T. cruzi infection induces a similar increase 
in CD36 receptor expression but results in an 
exacerbated inflammatory response on VAT in 
this obesity model
Excessive VAT accumulation is a main feature 
of obesity development and this tissue represents an 
important reservoir for parasites. Our results showed a 
dysfunctional VAT with the presence of hypertrophied 
adipocytes and crown-like structures (CLSs) on DIO group 
(Figure 5A, on the left). Conversely, T. cruzi infection 
promoted a decrease in adipocyte size accompanied by an 
important increase in the number of infiltrating cells and 
CLSs, as observed in DIO+I group at 24 weeks (Figure 
5A, on the right). 
Interestingly, an increased CD36 protein expression 
in VAT was revealed in DIO and DIO+I compared to the 
respective control groups (Figure 5B).
It is widely known that oxidative stress is an 
important mechanism in the pathogenesis of obesity. 
Thus, we evaluated the extent of lipid peroxidation by 
thiobarbituric acid reactive substances (TBARs) in VAT; 
only DIO+I mice exhibited a significant increase in 
malonyldialdehyde (MDA) levels at 24 weeks (Figure 
5C).
Considering that MCP-1 is one of the key 
chemokines that regulate migration of monocytes/
macrophages into inflamed tissues, we analyzed the local 
production of this chemokine on VAT from DIO+I group 
and showed that MCP-1 was mainly localized on the 
CLSs of this dysfunctional tissue (Figure 6A). In addition, 
a flow citometric analysis of leukocytes isolated from 
SVF was performed at 12 weeks in order to study which 
macrophage phenotype was the prevalent on our model. At 
this time, a significant increase in the percentage of local 
infiltrating leukocytes was observed in DIO, DIO+I and 
LFD+I compared to LFD control mice (Figure 6B) and 
interestingly, a synergism was observed on DIO+I group. 
A prevalence of F4/80+CD11c-CD206+ (M2) over 
F4/80+CD11c+CD206- (M1) macrophages was shown in 
all experimental groups (Figure 6C). Notably, the highest 
absolute number of ATMs with a M2 switch polarization 
was found in DIO+I group. Further, a higher MCP-1 
production in M2 than in M1 macrophages was also 
observed in all groups (Figure 6D). 
Non-alcoholic fatty liver disease in diet- induced 
obesity is modulated by T. cruzi infection
At 12 weeks, the DIO model was able to induce 
the development of hepatic steatosis. Remarkably, a 
decrease in lipid deposition with an exacerbated local 
inflammatory response was detected in DIO+I compared 
to DIO group (Figure 7A). Supporting these results, we 
found a two- to three-fold increase of hepatic TG in WT 
DIO in relation to DIO+I group at 24 weeks (Figure 7B, 
on the left). While infection seemed to improve hepatic 
steatosis, alanine aminotransferase (ALT) enzymatic levels 
were significantly increased in plasma from WT DIO+I vs. 
DIO group at 24 weeks (Figure 7C, on the left). TLR4-/- 
mice showed no significant changes in ALT levels (Figure 
7C, on the right). Interestingly, hepatic TG levels were 
significantly elevated only in TLR4-/- DIO group at 12 and 
24 weeks, while in DIO+I, these levels were comparable 
to those of the LFD mice (Figure 7B, on the right). 
Diet leads to an increased parasitemia, myocardial 
inflammatory infiltrate and parasite load during 
acute T. cruzi infection
Our results revealed that parasitemia was higher in 
DIO+I than in LDF+I group, reaching a first parasitemia 
peak at 20 days post-infection. Some animals from DIO+I 
group showed a second peak at 35 days, just before 
they finally died (Figure 8A). Remarkably, detectable 
amastigote nests with strong myocardial inflammatory 
infiltrates were seen in this group at 35 days (Figure 8B). 
Supporting these observations, the cardiac parasite load 
measured at 4 weeks revealed significantly higher levels 
of parasite DNA in DIO+l in comparison to LFD+I mice 
(Figure 8C). Also, a minor percentage of survival was 
found in DIO+I group up to 90 days post infection (Figure 
8D). 
DISCUSSION
Obesity continues to grow worldwide, making it 
imperative that animal models sharing characteristics 
of human obesity and its co-morbidities be developed 
in the search for innovative treatments [18]. The cluster 
of metabolic alterations accompanying obesity has been 
extensively studied using HFD or genetic mouse models 
[1]. Metabolic disorders have been observed in humans 
and animals with high daily fructose (15-30%) intakes, 
but whether fructose consumed in a low amount has 
deleterious effects, is still unknown [19]. There is evidence 
supporting the role of high doses of STZ as an inductor of 
experimental T1D model [20]. We demonstrate for the first 
time that the mere feeding with a MFD and a low fructose 
concentration, combined with a minimal dose of STZ, lead 
to the development of a novel non-extreme DIO model. 
Our findings showed the induction of IR and progression 
to T2D, dyslipidemia, hyperleptinemia, cardiovascular 
abnormalities and hepatic steatosis. This model displayed 
a time-dependent increase in body weight attributable to 
diet composition, since no difference on food intake was 
appreciated between LFD and MFD (data not shown). On 
diet group, dyslipidemia and hyperglycemia associated 
to high insulin levels and an increase in the percentage 
of VAT and hepatic TG deposition were observed at 12 
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Figure 7: Non-alcoholic fatty liver disease in DIO model is modulated by T. cruzi infection. A. Representative hematoxylin 
and eosin images of hepatic tissue from all groups (400x): DIO image with an insert for LFD group (on the left), DIO+I image with an insert 
for LFD+I group (on the right). Arrow represents lipid content and arrowhead, inflammatory foci. Scale bar = 40μm. B. Hepatic triglyceride 
content was determined for all groups from WT and TLR4-/-mice and expressed as mg/g of liver tissue. C. Plasma ALT enzymatic levels of 
WT and TLR4-/-groups. Results are representative of one experiment of two performed. Data are shown as mean ± SEM of seven mice per 
group. Significance of differences using two-way ANOVA is indicated as follows: DIO vs. LFD: ** p < 0.01. DIO vs. DIO+I: ффф p < 0.001, 
ф p < 0.05. TLR4-/- DIO vs. LFD:* p < 0.05; TLR4-/- DIO vs. DIO+I: фp < 0.05. 
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and 24 weeks. In addition, insulin and leptin resistance 
states were clearly developed, as described in other DIO 
and genetic models [21, 22]. It is known that a high flux 
of fructose to the liver perturbs glucose metabolism and 
glucose uptake pathways, leading to an enhancement of 
de novo TG synthesis which underlies the induction of IR 
[19, 23].
Interestingly, acute parasite infection in DIO+I 
induced a high insulin secretion which was able to 
maintain near to normal glucose levels, but during 
the chronic phase of infection, hyperglycemia was 
accompanied by low insulin levels, which may result in 
a progression to diabetes. In this regard, Nagajyothi et al. 
(2013) demonstrated that T. cruzi infection (Brazil strain) 
induced pancreatic inflammation and β-cell parasitism, 
which resulted in low insulin levels during the acute and 
chronic phase of infection [24]. Discrepancies observed 
in the acute phase could be attributed to differences on the 
assayed experimental conditions. 
Recently, a clear mechanistic link has been 
demonstrated between pancreatic β-cell dysfunction and 
inflammation via the FFA-TLR4/MyD88 pathway [25, 26]. 
Remarkably, we reported that the lack of TLR4 signaling 
improves glucose and lipid metabolism, and protected 
from obesity development and premature atherosclerosis. 
However, its absence did not protect from lipid deposition 
in liver. We speculate that fructose could be responsible 
for this phenomenon since it is a key contributing factor 
for the synthesis of de novo TG [19], and TLR4 signaling 
may not be involved in mediating this effect. 
Figure 8: Diet leads to an increased parasitemia, myocardial inflammatory infiltrate and parasite load during acute T. 
cruzi infection. A. Parasitemias were determined at different days after T. cruzi infection in DIO+I and LFD+I mice, n = seven mice per 
group. B. A representative hematoxylin and eosin heart image from DIO+I mouse at 35 days post infection is shown (400x). Black arrow 
indicates an amastigote nest and white arrows indicate inflammatory cell-infiltrations. Scale bar = 20μm. C. Quantitative assessment of 
the parasite load by q-PCR in hearts of the infected groups. Parasite quantification in DNA samples was performed amplifying a T. cruzi 
satellite sequence at 4 weeks. The relative load of parasites was normalized against the GADPH housekeeping gene control. Data are 
shown as mean ± SEM of four mice per group from one experiment representative of two performed. **p < 0.01 using Student´s t test for 
comparison between infected groups. D. Percentage of survival from infected LFD and DIO groups.
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Cardiovascular histomorphologic abnormalities 
observed in DIO mice were modified by parasite infection 
[27, 28]. T. cruzi infection induced a reduction on tissue 
lipid content together with an increased cell infiltration. 
The activation of host and/or T. cruzi lipases could 
be involved in tissue lipid reduction [15, 24, 29-31]. 
Additionally, chronic infection improved TG and TC 
plasma levels compared to DIO mice, in accordance to 
that reported by Nagajyothi et al. (2014) during the acute 
phase of infection in a HFD (60%) model [29]. This 
improvement could be due to the fact that this protozoan 
parasite has an incomplete de novo lipid metabolic 
machinery and needs to scavenge host lipids for its growth 
[30]. 
Considering that inflammation, hypercholestero 
-lemia, and infection are pro-atherogenic risk factors, 
we evaluated apoB100 levels together with a systemic 
lipoprotein pattern analysis. Strikingly, the abnormal 
apoB100/lipoprotein pattern observed in DIO, DIO+I and 
LFD+I mice, suggests that diet and infection themselves 
could be able to contribute to an early pro-atherogenic 
state [32-35]. In line with our observations, it is known 
that T. cruzi has a high affinity for host lipoproteins/
cholesterol and it uses lipids and LDL receptor for cell 
invasion [34]. 
We reported that parasite infection under an 
obesogenic diet context resulted in a strong systemic 
and local inflammatory response. This could probably 
explain the acute IR, tissue lipolysis, and body weight loss 
found in this study. Thus, we observed an intense acute 
inflammatory response produced by the increase in acute 
phase proteins and a wide range of plasma cytokines as 
TNF-α, IL-6 and MCP-1 in DIO+I group, as demonstrated 
in other reports [15, 29]. During chronic infection, this 
systemic inflammatory milieu was also encountered but 
to a lesser extent. Although T. cruzi infection improved 
leptin resistance in this DIO model, this adipokine remain 
elevated in relation to control groups. Leptin alterations in 
the acute phase of infection had been already reported by 
other authors [29, 36]. In line, T. cruzi invades the brain, 
affecting the central nervous system endocrine pathways, 
which may perturb insulin [24] and leptin secretion. 
Consistent with other reports, adiponectin levels 
were reduced during acute parasite infection [36]. Our 
results provide the first evidence in demonstrating a 
sustained decrease in adiponectin levels during the 
chronic phase of infection,which could be considered as 
an additional cardiovascular risk factor for DIO+I and 
LFD+I groups [37]. Interestingly, an intense myocardial 
inflammatory process with a concomitant high parasite 
load was observed in DIO+I mice during the acute phase 
of infection. These findings could be responsible, at least 
in part, for the development of the more severe acute/
chronic myocardiopathy reported in this group. 
Visceral AT immune function was modulated by 
both, diet and parasite infection. In this regard, a similar 
CD36 receptor expression was induced in DIO and DIO+I 
groups, but not in LFD+I group. Because parasites were 
not able to synergize CD36 expression, we consider diet 
as a key contributing factor for this phenomenon. Thus, 
we speculate that it may be up-regulated by danger signals 
like high glucose concentrations, long-chain fatty acids 
and/or oxLDL[17]. Moreover, CD36-deficiency is strongly 
associated to increased lipolysis and reduced adipogenesis 
in mice [38, 39]. 
Among the chemokines produced from obese 
VAT, MCP-1 and its receptor CCR-2 appear to be 
particularly important [8]. It was recently revealed that 
M2 macrophages are capable to proliferate within CLSs 
[10]. Of note, intracellular MCP-1 expression was found 
in CLSs in DIO+I mice.
Importantly, all experimental groups showed a 
strong VAT leukocyte infiltration compared to LFD group. 
Previous studies have shown an increase in F4/80+ cells 
on AT from T. cruzi infected mice [15, 29]. In this study, 
we have characterized for the first time the infiltrating cells 
in VAT, and found a predominant M2-like phenotype in 
all groups. A synergism on MCP1+ M2 macrophages was 
observed in DIO+I compared to DIO and LFD+I groups. 
We highlight that although predominant M1 phenotype 
has been reported by our group in T. cruzi infected liver 
tissue [16], ATMs showed a counteracting behavior. 
Thus, we hypothesized that in VAT, M1 macrophages 
could have died during the inflammatory process for 
killing this pathogen, and/or M2 could have proliferated 
to maintain tissue homeostasis and to promote parasite 
survival. These findings reinforce the notion that VAT 
has a clue role as a T. cruzi reservoir. Considering that 
parasite persistence is central for the etiology of Chagas 
cardiomyopathy, the predominance of M2 macrophages 
in this tissue could have a high impact on favoring the 
triggering of myocardial parasitism during the reactivation 
of infection in chagasic patients. Consistent to the strong 
cell infiltration in VAT from DIO+I mice, an enhanced 
lipid peroxidation compared to DIO and LFD+I mice was 
appreciated at 24 weeks. To our knowledge, this is the 
first evidence reporting a potentiated oxidative stress in 
VAT during chronic T. cruzi infection in a concomitant 
obesogenic environment. Recently, Wen et al. (2014) 
described an oxidative stress process in AT during T. cruzi 
infection [40].
Together, our data suggest that T. cruzi could 
be a potent risk factor for the progression of obesity 
related-immunometabolic disorders such as diabetes and 
atherosclerosis.
We highlight that the knowledge of innate immune 
mechanisms and metabolic dysfunction implicated in 
obesity and its complications linked to chronic parasite 
infection may provide new therapeutic strategies for 
intervention in obesity and globalized Chagas disease.
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MATERIALS AND METHODS
Ethic statement
Animals were maintained at the Animal Resource 
Facility of the Facultad de Ciencias Químicas, Universidad 
Católica de Córdoba (UCC), Argentina, in agreement with 
the Guide to the Care and Use of Experimental Animals 
published by the Canadian Council on Animal Care 
(OLAW Assurance number A5802-01) and approved by 
the UCC ethic committee.
Animals and experimental design
C57BL/6J (B6) mice were purchased from the 
Facultad de Ciencias Veterinarias, Universidad Nacional 
de la Plata, Argentina and C57BL/10ScNJ mice lacking 
the Tlr4 gene (Tlr4lps-del mice) were from The Jackson 
Laboratory, Bar Harbor, ME, USA. Mice were maintained 
under a standard light cycle (12 h light/dark) and were 
allowed for free access to water and food. Six-to-
eight-week-old male mice were divided randomly and 
subjected either to a low fat diet (LFD, 3% Kcal fat) or 
diet-induced obesity treatment (DIO) with medium fat 
diet (MFD 14% Kcal fat), fructose in water (5%), and a 
single intraperitoneally (i.p) dose of streptozotocin (STZ, 
8 mg/Kg body weight). Infected mice were challenged i.p 
with 500 blood-derived trypomastigotes (Tulahuen strain) 
and submitted either to LFD (LFD+I) or DIO treatment 
(DIO+I). Mice were studied from 4 to 24 weeks. Body 
weight, waist diameter and VAT content were determined. 
LFD composition: 3% fat, 26% protein, 53% carbohydrate, 
8% crude fiber and 10% total mineral; MFD composition: 
14% fat and a similar composition in all respects apart 
from the total fat content. Bloodstream trypomastigotes 
were obtained by heart puncture from T. cruzi 
-infected B6 mice at the peak of parasitemia, and parasites 
were maintained by serial passages from mouse to mouse. 
Parasites were quantified in tail blood by using a Neubauer 
chamber, prior lysis with 0.87% ammonium chloride. 
Blood lipids and insulin resistance biomarkers
Blood samples were obtained from cardiac puncture 
at 4, 12 and 24 weeks. Plasma triglycerides (TG, mg/
dL), total cholesterol (TC, mg/dL), glucose (mg/dL) and 
alanine aminotransferase-activity (ALT, U/L) levels were 
assessed by enzymatic kits (Roche) with a Hitachi modular 
P800 auto-analyzer, after 12 hour fasting. Insulin (μU/
mL) levels were quantified by insulin RIA kit DPC Coat A 
Count (Siemens) using Ingetron MODEL MN2200-E after 
8 hours fasting and Homeostasis Model of Assessment-
Insulin Resistance (HOMA-IR) was calculated as fasting 
plasma insulin (μU/mL) x fasting blood glucose (mg/dL) 
/ 405. Apolipoprotein B100 (mg/dL) levels were analyzed 
by an immunoturbidimetry method (Serapak-Bayer) using 
Modular P800 auto-analyzer, according to manufacturer’s 
instructions. Lipoprotein pattern was assessed based on 
3% polyacrylamide slab gel electrophoresis method as 
described [41], using a TRIS-glycine pH 7.5 buffer.
Histological analysis
Visceral adipose tissue, heart, abdominal 
aorta and liver specimens (5µm) were fixed in 4% 
paraformaldehyde-PBS pH7.4 and embedded in 
paraffin for hematoxylin and eosin (H&E), and 
immunofluorescence (IF) studies. For IF, VAT sections 
were deparaffinized and rehydrated, blocked using PBS 
containing 2% (w/v) BSA, and incubated with primary 
antibodies. A specific fluorescence rabbit anti-mouse 
antibody for monocyte chemotactic protein1 (MCP-1, 
CCL-2) (Biolegend) was used. After washing, the sections 
were incubated with FITC-conjugated anti-rabbit antibody 
(Biolegend). Nuclei were labeled using DNA-binding 
fluorochrome Hoechst 33258 (2µg/mL). Images were 
obtained using a Nikon Eclipse TE 2000U equipped with 
a digital video camera. 
Cytokine assays
ELISA sandwich was performed for quantification 
of cytokine and adipokine plasma concentrations, as 
described in our previous study [16]. All regents were 
purchased from BD Pharmingen and e-Bioscience. 
Adiponectin and leptin levels were quantified using 
commercially available ELISA Kits from Abcam and 
Invitrogen, respectively, and performed according to 
manufacturer’s instructions.
Western blot analysis
Visceral adipose tissue was lysed in RIPA buffer 
(50mM Tris-HCl pH7.4, 150mM NaCl, 1%Triton X-100, 
0.1%SDS) containing a protease inhibitor cocktail 
(Sigma-Aldrich) for 30 min, on ice. Equal amounts of 
protein determined by Bradford assay [42] from each 
sample were submitted to electrophoresis on 10% SDS-
PAGE gels and transferred to nitrocellulose membranes 
(Millipore, Bedford, MA). A CD36 specific rabbit anti-
mouse antibody (Santa Cruz) was used. Horseradish 
peroxidase-conjugated rabbit anti-mouse immunoglobulin 
(Santa Cruz) was used to detect specific protein bands 
using a chemiluminescence system (ECL reagent). For 
loading control, membranes were incubated with anti-β 
actin antibody (Santa Cruz). The bands were quantified 
using Image J software.
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Lipid peroxidation
We evaluated the extent of lipid peroxidation 
products, i.e. MDA using the TBARS assay as described 
[43], with some modifications. Briefly, tissue lysates 
(1:10w/v) were mixed with 0.2ml of 8.1% SDS, 1.5ml of 
20% acetic acid pH3.5, and 1.5ml of 0.8% thiobarbituric 
acid (TBA, Sigma). The mixture was heated at 95°C for 
60 min. After cooling on ice, samples were centrifuged 
at 4000rpm for 10min, and read at 532 nm using a 
spectrophotometer (HACH, model DR5000). The level of 
lipid peroxides was expressed in terms of µmol MDA/µg 
protein.
Isolation of the SVF of adipose tissue
Mouse epididymal AT was minced and digested 
for 45min at 37°C with type 2 collagenase (0.8mg/ml; 
Sigma) in Hanks’ Balanced Salt solution (pH7.4). After 
the addition of 3vol PBS containing 5%FBS and filtration 
of the digested tissue through nylon mesh (100μm), the 
filtrate was centrifuged at 200g. The SVF was obtained 
from the resulting supernatant [44].
Flow cytometry
The SVF of mouse epididymal AT was prepared as 
described above. Red blood cells present in this fraction 
were separated by centrifugation a 500g for 5min, and 
the remaining cells were suspended in PBS and exposed 
to FcBLOCK (BD Biosciences) for 20min. One million 
of SVF cells were washed in ice-cold FACS buffer 
(PBS-2%FBS) and incubated with fluorochrome labeled 
antibodies for 20min at 4°C. Different combinations of 
the following antibodies were used: PECy7-labeled:anti- 
F4/80, APCCy7-labeled:anti- CD11c, biotin-labeled:anti-
CD206 and SA-PECy5. Cells were permeabilized with 
BD Cytofix/ Cytoperm and Perm/Wash (BD Biosciences) 
for detecting intracellular MCP-1, according to 
manufacturer’s instruction. Then, cells were incubated 
with PE-labeled antibody for MCP-1. Cells were acquired 
on FACS Canto II (BD Bioscience).
Measurement of TG in the liver
Liver tissues (1 g) were homogenized with 1 mL of 
cold PBS using a hand homogenizer. Homogenates were 
centrifuged at 5000 rpm for 10min at 4°C. The supernatant 
was then collected, and TG content was determined using 
commercial enzymatic kits (Roche) in a Hitachi modular 
P800 auto-analyzer.
Myocardial parasite load
For determination of tissue parasitism, genomic 
DNA was purified from heart of WT LFD+I and DIO+I 
mice obtained at 4 weeks, using TRIzol reagent and 
following manufacturer´s instructions. Satellite DNA 
from T. cruzi (GenBank AY520036) was quantified by 
real time PCR using specific Custom Taqman Gene 
Expression Assay (Applied Biosystem) using the primers 
and probe sequences described by Piron et al. (2007) [45]. 
A sample containing 1 µg of genomic DNA was amplified. 
Abundance of satellite DNA from T. cruzi was normalized 
to GAPDH abundance (Taqman Rodent GAPDH Control 
Reagent, Applied Biosystem) and expressed as arbitrary 
units.
Statistical analysis
Results are expressed as means ± SEM. 
Comparisons among groups were performed using 
the parametric analysis of variance (one way or two 
way- ANOVA) followed by a multiple-comparison test 
(Bonferroni test) using Graph Pad Prism Inc., La Jolla, 
CA. A p-value < 0.05 was considered significant. 
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